Niagen Bioscience (NAGE) announced OneSpaWorld (OSW) as the newest Niagen Plus provider, engaged to offer pharmaceutical grade Niagen IV at over 80 Medi-Spa clinics onboard high-end cruise ships. Marking Niagen Bioscience’s first cruise ship clinic partnership, this collaboration brings Niagen IV to guests at sea. Rob Fried, CEO of Niagen Bioscience, commented, “OneSpaWorld opens a new premium channel at sea, strengthens our rapidly expanding Niagen Plus clinic footprint, and supports our strategy to scale Niagen IV and injections outside of the U.S.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NAGE:
- Niagen Bioscience Doubles Share Repurchase Authorization to $20M
- Niagen Bioscience increases share repurchase program to $20M
- VGT vs. VOO vs. VDC: Which Vanguard ETF Has More Upside in 2026?
- Niagen Bioscience price target lowered to $13 from $14 at Canaccord
- Niagen Bioscience: Tru Niagen‑Driven Beat, Durable Double‑Digit Growth Outlook, and FDA Litigation Upside Support Buy Rating